Copyright Reports & Markets. All rights reserved.

Global Narcolepsy Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Central nervous system stimulants
    • 1.4.3 Sodium Oxybate
    • 1.4.4 Selective Serotonin Reuptake Inhibitor (SSRI)
    • 1.4.5 Tricyclic Antidepressants
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Narcolepsy Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Narcolepsy With Cataplexy
    • 1.5.3 Narcolepsy Without Cataplexy
    • 1.5.4 Secondary Narcolepsy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Narcolepsy Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Narcolepsy Therapeutics Growth Trends by Regions
    • 2.2.1 Narcolepsy Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Narcolepsy Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Narcolepsy Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Narcolepsy Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Narcolepsy Therapeutics Players by Market Size
    • 3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Narcolepsy Therapeutics Market Concentration Ratio
    • 3.2.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2019
  • 3.3 Narcolepsy Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Narcolepsy Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Narcolepsy Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Narcolepsy Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Narcolepsy Therapeutics Market Size (2015-2020)
  • 6.2 Narcolepsy Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Narcolepsy Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Narcolepsy Therapeutics Market Size (2015-2020)
  • 7.2 Narcolepsy Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Narcolepsy Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Narcolepsy Therapeutics Market Size (2015-2020)
  • 8.2 Narcolepsy Therapeutics Key Players in China (2019-2020)
  • 8.3 China Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Narcolepsy Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Narcolepsy Therapeutics Market Size (2015-2020)
  • 9.2 Narcolepsy Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Narcolepsy Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Narcolepsy Therapeutics Market Size (2015-2020)
  • 10.2 Narcolepsy Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Narcolepsy Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Narcolepsy Therapeutics Market Size (2015-2020)
  • 11.2 Narcolepsy Therapeutics Key Players in India (2019-2020)
  • 11.3 India Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Narcolepsy Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Narcolepsy Therapeutics Market Size (2015-2020)
  • 12.2 Narcolepsy Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Narcolepsy Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Narcolepsy Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Addrenex Pharmaceuticals, Inc.
    • 13.1.1 Addrenex Pharmaceuticals, Inc. Company Details
    • 13.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
    • 13.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
    • 13.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020))
    • 13.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
  • 13.2 Teva Pharmaceutical Industries Ltd.
    • 13.2.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 13.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
    • 13.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
    • 13.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
  • 13.3 Jazz Pharmaceuticals PLC
    • 13.3.1 Jazz Pharmaceuticals PLC Company Details
    • 13.3.2 Jazz Pharmaceuticals PLC Business Overview
    • 13.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
    • 13.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.3.5 Jazz Pharmaceuticals PLC Recent Development
  • 13.4 Graymark Healthcare, Inc.
    • 13.4.1 Graymark Healthcare, Inc. Company Details
    • 13.4.2 Graymark Healthcare, Inc. Business Overview
    • 13.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
    • 13.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.4.5 Graymark Healthcare, Inc. Recent Development
  • 13.5 Arena Pharmaceuticals, Inc.
    • 13.5.1 Arena Pharmaceuticals, Inc. Company Details
    • 13.5.2 Arena Pharmaceuticals, Inc. Business Overview
    • 13.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
    • 13.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.5.5 Arena Pharmaceuticals, Inc. Recent Development
  • 13.6 BIOPROJET
    • 13.6.1 BIOPROJET Company Details
    • 13.6.2 BIOPROJET Business Overview
    • 13.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
    • 13.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.6.5 BIOPROJET Recent Development
  • 13.7 Takeda
    • 13.7.1 Takeda Company Details
    • 13.7.2 Takeda Business Overview
    • 13.7.3 Takeda Narcolepsy Therapeutics Introduction
    • 13.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.7.5 Takeda Recent Development
  • 13.8 Ligand Pharmaceuticals, Inc.
    • 13.8.1 Ligand Pharmaceuticals, Inc. Company Details
    • 13.8.2 Ligand Pharmaceuticals, Inc. Business Overview
    • 13.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
    • 13.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
    • 13.8.5 Ligand Pharmaceuticals, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Narcolepsy Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Addrenex Pharmaceuticals, Inc.
    Teva Pharmaceutical Industries Ltd.
    Jazz Pharmaceuticals PLC
    Graymark Healthcare, Inc.
    Arena Pharmaceuticals, Inc.
    BIOPROJET
    Takeda
    Ligand Pharmaceuticals, Inc.

    Market segment by Type, the product can be split into
    Central nervous system stimulants
    Sodium Oxybate
    Selective Serotonin Reuptake Inhibitor (SSRI)
    Tricyclic Antidepressants
    Others
    Market segment by Application, split into
    Narcolepsy With Cataplexy
    Narcolepsy Without Cataplexy
    Secondary Narcolepsy

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now